Skip to content
10-Q

Quarterly Report

CARLSMED, INC. CARL

0001794546-26-000011

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 27.18M sh
Shares Diluted Q1 2026 · Mar 31, 2026 26.84M sh
Shares Diluted Q1 2026 · Mar 31, 2025 4.3M sh
Capex Q1 2026 · Mar 31, 2026 $79K
Capex Q1 2026 · Mar 31, 2025 $83K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$13.01M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$8.16M
Long Term Debt Q1 2026 · Mar 31, 2026 $15.36M
Long Term Debt Q1 2026 · Dec 31, 2025 $15.35M
Short Term Investments Q1 2026 · Mar 31, 2026 $24M
Short Term Investments Q1 2026 · Dec 31, 2025 $24M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $73.02M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $85.79M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $43.43M
Cash And Equivalents Q1 2026 · Dec 31, 2024 $40.13M
Stockholders Equity Q1 2026 · Mar 31, 2026 $92.25M
Stockholders Equity Q1 2026 · Dec 31, 2025 $98.87M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$76.61M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$70.63M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.72M
Current Liabilities Q1 2026 · Dec 31, 2025 $14.28M
Total Liabilities Q1 2026 · Mar 31, 2026 $26.52M
Total Liabilities Q1 2026 · Dec 31, 2025 $31.25M
Current Assets Q1 2026 · Mar 31, 2026 $115.41M
Current Assets Q1 2026 · Dec 31, 2025 $126.67M
Total Assets Q1 2026 · Mar 31, 2026 $118.77M
Total Assets Q1 2026 · Dec 31, 2025 $130.12M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.47
Eps Basic Q1 2026 · Mar 31, 2026 −$0.32
Eps Basic Q1 2026 · Mar 31, 2025 −$1.47
Sga Expense Q1 2026 · Mar 31, 2026 $6.23M
Sga Expense Q1 2026 · Mar 31, 2025 $3.47M
Rd Expense Q1 2026 · Mar 31, 2026 $5.18M
Rd Expense Q1 2026 · Mar 31, 2025 $3.15M
Net Income Q1 2026 · Mar 31, 2026 −$8.7M
Net Income Q1 2026 · Mar 31, 2025 −$5.73M
Operating Income Q1 2026 · Mar 31, 2026 −$9.28M
Operating Income Q1 2026 · Mar 31, 2025 −$5.72M
Gross Profit Q1 2026 · Mar 31, 2026 $12.43M
Gross Profit Q1 2026 · Mar 31, 2025 $7.64M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $3.69M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $2.55M
Revenue Q1 2026 · Mar 31, 2026 $16.12M
Revenue Q1 2026 · Mar 31, 2025 $10.19M